risankizumab
abbvie
['risan', 'crohn', 'ibd']
the full reports of the phase 3 trials of risankizumab in crohn's disease are available in - induction: maintenance: #uegweek #ibd #gitwitter
The Lancet Gastroenterology & Hepatology publishes high-quality peer-reviewed research and reviews, comment, and news #gastroenterology #hepatology. IF=45.042